Avex Inc. (TYO:7860)
Japan · Delayed Price · Currency is JPY 1,265.00
-41.00 (-3.14%)
Aug 8, 2025, 3:30 PM JST
Marinus Pharmaceuticals Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 138,878 | 131,691 | 133,387 | 121,561 | 98,437 | 81,527 | Upgrade | |
Revenue Growth (YoY) | 9.38% | -1.27% | 9.73% | 23.49% | 20.74% | -39.82% | Upgrade |
Cost of Revenue | 100,395 | 95,852 | 94,097 | 82,574 | 63,209 | 55,908 | Upgrade |
Gross Profit | 38,483 | 35,839 | 39,290 | 38,987 | 35,228 | 25,619 | Upgrade |
Selling, General & Admin | 35,424 | 35,517 | 36,758 | 34,649 | 31,773 | 29,984 | Upgrade |
Operating Expenses | 37,565 | 37,658 | 38,024 | 35,602 | 32,645 | 31,897 | Upgrade |
Operating Income | 918 | -1,819 | 1,266 | 3,385 | 2,583 | -6,278 | Upgrade |
Interest Expense | -7 | -5 | -6 | -9 | -11 | -88 | Upgrade |
Interest & Investment Income | 86 | 70 | 35 | 26 | 35 | 26 | Upgrade |
Earnings From Equity Investments | 389 | 310 | 13 | -20 | -218 | -337 | Upgrade |
Currency Exchange Gain (Loss) | -126 | -23 | -344 | -146 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -85 | -98 | -51 | 65 | -40 | 137 | Upgrade |
EBT Excluding Unusual Items | 1,175 | -1,565 | 913 | 3,301 | 2,349 | -6,540 | Upgrade |
Gain (Loss) on Sale of Investments | 6,181 | 6,242 | 1,850 | 2,125 | 78 | 1,652 | Upgrade |
Gain (Loss) on Sale of Assets | -4,548 | - | - | - | 2 | 28,757 | Upgrade |
Asset Writedown | -516 | -496 | -132 | -921 | -201 | -1,869 | Upgrade |
Legal Settlements | - | - | -160 | - | - | - | Upgrade |
Other Unusual Items | -253 | -420 | 293 | 144 | 1 | -2,486 | Upgrade |
Pretax Income | 2,039 | 3,761 | 2,764 | 4,649 | 2,229 | 19,514 | Upgrade |
Income Tax Expense | 1,682 | 2,420 | 1,584 | 1,626 | 1,148 | 6,353 | Upgrade |
Earnings From Continuing Operations | 357 | 1,341 | 1,180 | 3,023 | 1,081 | 13,161 | Upgrade |
Minority Interest in Earnings | -292 | -203 | -193 | -281 | -162 | -330 | Upgrade |
Net Income | 65 | 1,138 | 987 | 2,742 | 919 | 12,831 | Upgrade |
Net Income to Common | 65 | 1,138 | 987 | 2,742 | 919 | 12,831 | Upgrade |
Net Income Growth | -44.44% | 15.30% | -64.00% | 198.37% | -92.84% | - | Upgrade |
Shares Outstanding (Basic) | 43 | 44 | 45 | 45 | 44 | 43 | Upgrade |
Shares Outstanding (Diluted) | 43 | 44 | 45 | 45 | 44 | 43 | Upgrade |
Shares Change (YoY) | -5.22% | -3.56% | 0.24% | 1.86% | 2.90% | -0.91% | Upgrade |
EPS (Basic) | 1.52 | 26.10 | 21.83 | 60.78 | 20.75 | 298.10 | Upgrade |
EPS (Diluted) | 1.52 | 26.10 | 21.83 | 60.78 | 20.75 | 298.10 | Upgrade |
EPS Growth | -41.39% | 19.56% | -64.09% | 192.88% | -93.04% | - | Upgrade |
Free Cash Flow | - | -7,369 | 1,398 | 8,061 | -5,123 | -8,535 | Upgrade |
Free Cash Flow Per Share | - | -168.98 | 30.92 | 178.70 | -115.67 | -198.29 | Upgrade |
Dividend Per Share | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 | 121.000 | Upgrade |
Dividend Growth | - | - | - | - | -58.68% | 142.00% | Upgrade |
Gross Margin | 27.71% | 27.21% | 29.46% | 32.07% | 35.79% | 31.42% | Upgrade |
Operating Margin | 0.66% | -1.38% | 0.95% | 2.79% | 2.62% | -7.70% | Upgrade |
Profit Margin | 0.05% | 0.86% | 0.74% | 2.26% | 0.93% | 15.74% | Upgrade |
Free Cash Flow Margin | - | -5.60% | 1.05% | 6.63% | -5.20% | -10.47% | Upgrade |
EBITDA | 2,484 | -212 | 3,038 | 5,731 | 4,753 | -3,390 | Upgrade |
EBITDA Margin | 1.79% | -0.16% | 2.28% | 4.71% | 4.83% | -4.16% | Upgrade |
D&A For EBITDA | 1,566 | 1,607 | 1,772 | 2,346 | 2,170 | 2,888 | Upgrade |
EBIT | 918 | -1,819 | 1,266 | 3,385 | 2,583 | -6,278 | Upgrade |
EBIT Margin | 0.66% | -1.38% | 0.95% | 2.79% | 2.62% | -7.70% | Upgrade |
Effective Tax Rate | 82.49% | 64.34% | 57.31% | 34.98% | 51.50% | 32.56% | Upgrade |
Advertising Expenses | - | 7,912 | 8,048 | 8,353 | 7,992 | 6,875 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.